Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.483
-0.008 (-1.57%)
At close: Nov 22, 2024, 4:00 PM
0.510
+0.027 (5.52%)
After-hours: Nov 22, 2024, 5:39 PM EST
Spruce Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -39.43 | -47.92 | -46.18 | -42.29 | -29.54 | -13.09 | |
| Depreciation & Amortization | 0.05 | 0.07 | 0.07 | 0.07 | 0.04 | 0.01 | |
| Loss (Gain) From Sale of Assets | 0 | 0 | 0.04 | - | - | - | |
| Loss (Gain) From Sale of Investments | -0.07 | -0.64 | 0.02 | 0.12 | - | - | |
| Stock-Based Compensation | 5.61 | 4.62 | 3.63 | 3.96 | 0.76 | 0.2 | |
| Other Operating Activities | 0.24 | 0.23 | -0.4 | 0.31 | 0.07 | - | |
| Change in Accounts Payable | -1.35 | 1.91 | -1.4 | -0.81 | 3.73 | -0.23 | |
| Change in Unearned Revenue | -7.1 | 4.91 | - | - | - | - | |
| Change in Other Net Operating Assets | -4.45 | 3.54 | 2.53 | 2.76 | -2.57 | 0.49 | |
| Operating Cash Flow | -46.5 | -33.28 | -41.68 | -35.88 | -27.52 | -12.62 | |
| Capital Expenditures | - | -0.01 | -0.01 | -0.09 | -0.07 | -0 | |
| Investment in Securities | 9.3 | 55.78 | 23.7 | -79.08 | - | - | |
| Investing Cash Flow | 9.3 | 55.78 | 23.69 | -79.17 | -0.07 | -0 | |
| Long-Term Debt Issued | - | - | - | 5 | - | 4.5 | |
| Long-Term Debt Repaid | - | -1.62 | - | -4.77 | - | - | |
| Net Debt Issued (Repaid) | -1.62 | -1.62 | - | 0.23 | - | 4.5 | |
| Issuance of Common Stock | 0.3 | 53.79 | 0.08 | 0.46 | 93.4 | - | |
| Repurchase of Common Stock | -0.23 | -0.31 | -0.04 | - | - | - | |
| Other Financing Activities | - | -2.72 | -0.28 | -0.05 | - | -0.01 | |
| Financing Cash Flow | -1.55 | 49.14 | -0.24 | 0.64 | 181.04 | 12.43 | |
| Net Cash Flow | -38.75 | 71.64 | -18.23 | -114.4 | 153.44 | -0.19 | |
| Free Cash Flow | -46.5 | -33.28 | -41.69 | -35.97 | -27.59 | -12.62 | |
| Free Cash Flow Margin | -654.78% | -329.88% | - | - | - | - | |
| Free Cash Flow Per Share | -1.13 | -0.86 | -1.77 | -1.54 | -4.61 | -16.51 | |
| Cash Interest Paid | 0.37 | 0.37 | 0.27 | 0.21 | 0.19 | 0.02 | |
| Levered Free Cash Flow | -34.36 | -17.52 | -25.55 | -20.7 | -16.48 | -7.75 | |
| Unlevered Free Cash Flow | -34.14 | -17.22 | -25.28 | -20.49 | -16.28 | -7.71 | |
| Change in Net Working Capital | 12.77 | -10.59 | -0.57 | -1.87 | -1.39 | -0.28 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.